General Information of the Compound
| Compound ID |
CP0560465
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
[(3aS,6aR)-2-(4,5,6-trimethylpyrimidin-2-yl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H27N7O
|
||||||||||||||||||
| Molecular Weight |
417.517
|
||||||||||||||||||
| Canonical SMILES |
Cc1ccc(c(c1)C(=O)N1C[C@H]2CN(C[C@H]2C1)c1nc(C)c(C)c(C)n1)-n1nccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H27N7O/c1-14-5-6-21(30-24-7-8-25-30)20(9-14)22(31)28-10-18-12-29(13-19(18)11-28)23-26-16(3)15(2)17(4)27-23/h5-9,18-19H,10-13H2,1-4H3/t18-,19+
Show/Hide
|
||||||||||||||||||
| InChIKey |
ASVYPVLQERHICK-KDURUIRLSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1